{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:04:19Z","timestamp":1776261859159,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1582,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2362.2011.02531.x","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T06:36:21Z","timestamp":1304404581000},"page":"1227-1236","source":"Crossref","is-referenced-by-count":61,"title":["High prevalence of autonomous aldosterone secretion among patients with essential hypertension"],"prefix":"10.1111","volume":"41","author":[{"given":"Aggeliki","family":"Gouli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kaltsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Tzonou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis I.","family":"Androulakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Ragkou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriakos","family":"Vamvakidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Zografos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Kontogeorgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Piaditis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.beem.2006.07.007","article-title":"Screening for primary aldosteronism","volume":"20","author":"Schirpenbach","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00004872-200405000-00001","article-title":"The current epidemic of primary aldosteronism: causes and consequences","volume":"22","author":"Kaplan","year":"2004","journal-title":"J Hypertens"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","article-title":"Diagnosis and management of primary aldosteronism","volume":"2","author":"Stowasser","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0025-6196(11)62104-6","article-title":"Caution about the overdiagnosis of primary aldosteronism","volume":"76","author":"Kaplan","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1365-2265.2003.01817.x","article-title":"Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice","volume":"59","author":"Padfield","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","article-title":"Primary aldosteronism","volume":"339","author":"Ganguly","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.85.8.2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","article-title":"Comparison of confirmatory tests for the diagnosis of primary aldosteronism","volume":"91","author":"Mulatero","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after \u2018non-selective\u2019 screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J Hypertens"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.85.9.3141","article-title":"Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study","volume":"85","author":"Arvat","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/jcem-69-5-1028","article-title":"Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion","volume":"69","author":"Seely","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","article-title":"Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study","volume":"16","author":"Abdelhamid","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1210\/jc.85.5.1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.HYP.6.5.717","article-title":"Further evaluation of saline infusion for the diagnosis of primary aldosteronism","volume":"6","author":"Holland","year":"1984","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1530\/eje.1.02164","article-title":"Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites","volume":"154","author":"Schirpenbach","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB22|cit22","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2265.2009.03551.x","article-title":"High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas","volume":"71","author":"Piaditis","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3109\/10641968909038169","article-title":"Acute and chronic effect of nifedipine in primary aldosteronism","volume":"11","author":"Carpene","year":"1989","journal-title":"Clin Exp Hypertens A"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2004-1627","article-title":"Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas\/hyperplasias from nonadenomas: Cleveland clinic experience","volume":"90","author":"Hamrahian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0889-8529(05)70233-4","article-title":"Test characteristics and decision rules","volume":"26","author":"Barry","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2002-23491","article-title":"Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism","volume":"110","author":"Trenkel","year":"2002","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/eje.0.1500517","article-title":"Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass","volume":"150","author":"Unger","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004872-200402000-00023","article-title":"Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism","volume":"22","author":"Ferrari","year":"2004","journal-title":"J Hypertens"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","article-title":"Aldosterone to Renin ratio in a primary care setting: the Bussolengo study","volume":"89","author":"Olivieri","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.128.3.380","article-title":"Saline suppression of plasma aldosterone in hypertension","volume":"128","author":"Kem","year":"1971","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.0.1460523","article-title":"Primary aldosteronism in normokalemic patients with adrenal incidentalomas","volume":"146","author":"Bernini","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","article-title":"Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication","volume":"150","author":"Seiler","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","article-title":"Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature","volume":"31","author":"Montori","year":"2002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism - careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB41|cit41","first-page":"179","article-title":"Incidence and role of adrenocortical tumors in hypertension","volume":"23","author":"Salomon","year":"1968","journal-title":"Geriatrics"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.0954-6820.1968.tb02445.x","article-title":"On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes","volume":"184","author":"Hedeland","year":"1968","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1365-2362.2011.02531.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1365-2265.1998.00464.x","article-title":"The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing\u2019s syndrome","volume":"48","author":"Tsagarakis","year":"1998","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2011.02531.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2362.2011.02531.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T00:38:46Z","timestamp":1625359126000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2011.02531.x"}},"subtitle":["HIGH PREVALENCE OF AUTONOMOUS ALDOSTERONE SECRETION IN ESSENTIAL HYPERTENSION"],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2011.02531.x","relation":{},"ISSN":["0014-2972"],"issn-type":[{"value":"0014-2972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}